Valuation: RaySearch Laboratories AB

Market Cap 5.73B 583M 521M 479M 435M 824M 54.68B 845M 2.28B 29.28B 2.19B 2.14B 92.2B P/E 2026 *
23.3x
P/E 2027 * 18x
Enterprise Value 5.95B 606M 541M 497M 452M 856M 56.77B 877M 2.37B 30.39B 2.27B 2.22B 95.73B EV / Sales 2026 *
4.28x
EV / Sales 2027 * 3.61x
Free-Float
80.09%
Yield 2026 *
2.32%
Yield 2027 * 2.44%
1 day-2.52%
1 week-15.09%
Current month-15.09%
1 month-7.07%
3 months-4.28%
6 months-5.85%
Current year-24.47%
1 week 161.6
Extreme 161.6
179.7
1 month 161.6
Extreme 161.6
203.8
Current year 153.1
Extreme 153.1
238.4
1 year 153.1
Extreme 153.1
258.5
3 years 84.1
Extreme 84.1
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
18/8/26 Sell

Chief Technology Officer

-3,203 0.0104%
17/8/26 Sell

Chief Technology Officer

-2,297 0.0075%
11/6/26 Buy

General Counsel

462 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-2.55%-15.09%-32.87%+96.35% 595M
+3.87%+5.71%+25.21%+62.43% 257B
+2.12%+3.14%+11.34%+20.25% 162B
+1.71%+5.42%-20.07%+69.07% 157B
+2.97%-0.68%-56.38%-14.41% 61.96B
+2.52%+12.28%+24.54%+61.96% 58.73B
-3.36%+0.63%-0.30%-11.16% 55.42B
+3.10%+4.76%+23.10%+67.23% 49.27B
+0.88%-0.20%+3.60%+83.91% 49.18B
+4.17%+6.04%+26.59%+88.36% 44.96B
Average +1.58%+0.36%+0.48%+52.40% 89.65B
Weighted average by Cap. +2.42%+1.47%+6.24%+48.85%

Financials

2026 *2027 *
Net sales 1.39B 141M 126M 116M 105M 200M 13.26B 205M 554M 7.1B 531M 520M 22.36B 1.61B 164M 147M 135M 122M 232M 15.39B 238M 643M 8.24B 616M 603M 25.95B
Net income 248M 25.19M 22.48M 20.69M 18.78M 35.59M 2.36B 36.47M 98.65M 1.26B 94.55M 92.52M 3.98B 318M 32.42M 28.93M 26.62M 24.16M 45.79M 3.04B 46.93M 127M 1.63B 122M 119M 5.12B
Net Debt 219M 22.29M 19.9M 18.31M 16.62M 31.49M 2.09B 32.27M 87.29M 1.12B 83.66M 81.87M 3.52B 95M 9.67M 8.63M 7.94M 7.21M 13.66M 906M 14M 37.86M 485M 36.29M 35.51M 1.53B
Projected Income Statement - Annual - RaySearch Laboratories AB
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
477
Date Price Change Volume
10/11/26 SEK 172.20 -2.55% 135,578
06/11/26 SEK 176.70 +1.03% 119,241
05/11/26 SEK 174.90 +0.81% 186,222
04/11/26 SEK 173.50 +4.08% 404,408
03/11/26 SEK 166.70 -15.38% 1,356,311
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - RaySearch Laboratories AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
176.70SEK
Average target price
277.50SEK
Spread / Average Target
+57.05%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - RaySearch Laboratories AB
  1. Stock Market
  2. Stocks
  3. RAY B Stock